Fagron N.V.

AGM Information • May 10, 2017

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands)¹ , 9 May 2017

Fagron announces today that its annual general meeting of shareholders and the extraordinary shareholders meeting, both held on 8 May 2017, have adopted all proposed resolutions. The meeting approved the 2016 financial statements and discharged the directors and the statutory auditor who were active during the financial year 2016. The meeting also approved the co-optation by the board of directors of AHOK BVBA, permanently represented by Koen Hoffman as independent non-executive director, the co-optation by the board of directors of Vanzel G. Comm. V., permanently represented by Giulia Van Waeyenberge as independent non-executive director, the co-optation by the board of directors of Karin de Jong as executive director, the co-optation by the board of directors of Alychlo NV, permanently represented by Marc Coucke as non-executive director, and the co-optation by the board of directors of Marc Janssens as non-executive director.

After the meeting, Robert Peek announced his decision to step down as non-executive director and Chairman of the Board of Directors of Fagron. The Board of Directors decided to appoint Koen Hoffman as Chairman and to co-opt Veerle Deprez as independent non-executive director. The formal appointment of Veerle Deprez will be proposed to the next shareholders meeting of Fagron.

Hans Stols, CEO of Fagron: "We very much appreciate Robert Peek's valuable contribution to Fagron. In 2007, Robert was in charge of obtaining a public listing for Fagron. He was a driving force behind the successful transition from a business active in many areas of healthcare in North-west Europe to a leading global specialist in pharmaceutical compounding with prominent market positions in Europe, North America and South America. During the intensive period in which we realized the company's new financing, Robert demonstrated great professionalism, dedication and leadership. Now this has been completed and Fagron finds itself in the next phase, Robert made the decision to step down. We wish him all the best."

Composition Board of Directors (9 May 2017)

• AHOK BVBA, permanently represented by Koen Hoffman (Chairman)
• Vanzel G. Comm. V., permanently represented by Giulia Van Waeyenberge
• Management Deprez BVBA, permanently represented by Veerle Deprez
• Johannes (Hans) Stols (CEO, executive director)
• Karin de Jong (CFO, executive director)
• Holdco FV B.V., permanently represented by Frank Vlayen
• Matthias Geyssens
• WPEF VI Holdco III BE B.V., permanently represented by Nathalie Clybouw
• Marc Janssens
• Alychlo NV, permanently represented by Marc Coucke
• Michael Schenck BVBA, permanently represented by Michael Schenck

Veerle Deprez (1960)

Veerle Deprez created in 1987, together with her brother Hein Deprez, the foundation for what later on became the Univeg Group. Through acquisitions, Univeg became a vertically integrated group specialized in the production, packing and distribution of fruit and vegetables. In 2003 and 2004, Univeg acquired Peltracom and Agrofino, two companies active in potting soils, soil improvers and substrates. In 2005, the Deprez family took a stake in Pinguin, a Euronext quoted company, market leader in frozen vegetables. The range was extended with canned vegetables with the acquisition of Noliko in 2011. The three companies, Univeg, Pinguin and Peltracom, merged in 2015, the whole group being called now Greenyard. Greenyard is a global market leader in fresh, fresh frozen and prepared fruits and vegetables, flowers and plants, growing media and substrates and delivers to the majority of Europe's retailers. In her capacity of permanent representative, Veerle Deprez represents Management Deprez BVBA, since 2005, as non-executive director of Greenyard. Veerle is also directly or indirectly via Management Deprez BVBA, a director of DS Consult NV, De Kraaiberg NV, Nova Natie NV, De Weide Blik NV, The Fruit Farm Group BV, Deprez Holding NV, Deprez Invest NV and Food Invest International NV.

In case of inconsistencies, the Dutch press release prevails.

For more information: Constantijn van Rietschoten Chief Communications Officer Tel. +31 6 53 69 15 85 constantijn.van.rietschoten@fagron.com

Fagron profile

Fagron is a leading global company active in pharmaceutical compounding and focused on delivering tailored pharmaceutical care to hospitals, pharmacies, clinics and patients in 32 countries around the world.

The Belgian company Fagron NV is located in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.